|Dr Eric Chow with his VC award|
for ECR research excellence
Most recently, Eric was awarded:
- 2017 Vice-Chancellor's award for Excellence in Research by an Early Career Researcher
- 2017 Australasian Sexual Health Alliance (ASHA) award*
- 2017 AMREP EMCR Public Health Early Career Research Best Paper award**
- 2017 Victorian Young Tall Poppy Scientist of the year award
- 2017 Early Career Researcher Fellows Publication Prize
- 2017 Dean's award for Excellence in Research (Early Career)
**Dr Eric Chow, Melbourne Sexual Health Centre, Alfred Health and Central Clinical School, Monash University
Paper Title: Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study
Journal: Lancet Infectious Diseases
Lay summary: This is the first study to demonstrate falls in vaccine-preventable human papillomavirus (HPV) genotypes (6/11/16/18) in largely unvaccinated heterosexual men as a result of herd protection from vaccinated women from the national HPV vaccination programme in Australia.
The study looked over 11 years; 3 years before and 8 years after the female HPV vaccination programme. For the first time, I showed the prevalence of the four vaccine-preventable HPV genotypes (6/11/16/18) dramatically reduced from 20% in 2004/05 to 3% in 2014/15 among Australian-born men, suggesting these men received herd protection from their female partners. Interestingly, we found a decline in HPV 16/18 but not in HPV 6/11 among overseas travellers who were from countries (e.g. UK) with a bivalent vaccine (16/18 only) programme, suggests these men receive benefits from herd protection for 16/18 from their vaccinated female partners in their own countries.
Link to publication: https://www.ncbi.nlm.nih.gov/pubmed/27282422